chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No additional information provided; Nurse reporting that VARIVAX was administered to one patient after a temperature excursion. No additional information provided. No additional AE reported. No PQC reported.     ?    Names of vaccines involved (including lot/exp) VARIVAX (U029621 9/2; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On 02-MAY-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot number U029621, expiration date 22-SEP-2023 (dose and route of administration not reported) for prophylaxis (product storage error). No adverse event was reported.  The vaccine underwent a temperature excursion of 35 degress Farhrenheit for 17 hours and 37 minutes.
25JUL swelling from should to 3" distance to elbow;reddened & hot to touch;arm very sore but also dec in strength of muscle;hives on both arms, abd, & lower legs;30JUl swelling dec hard lump size of quarter-muscle strength improving;itching
Muscle pain on left arm where vaccine was administered; Generalized muscle pain; Muscle spams on left shoulder blade and neck; Cervical pain; Left ear ache; Tingling of left side of head, mouth and throat; Tingling of left side of head, mouth and throat; Tingling of left side of head, mouth and throat; This case was reported by a consumer and described the occurrence of injection site muscle pain in a 80-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th February 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site muscle pain, generalized muscle aches, muscle spasm, cervical pain, ear pain, tingling, tingling mouth and tingling throat. On an unknown date, the outcome of the injection site muscle pain, generalized muscle aches, muscle spasm, cervical pain, ear pain, tingling, tingling mouth and tingling throat were recovered/resolved.   It was unknown if the reporter considered the injection site muscle pain, generalized muscle aches, muscle spasm, cervical pain, ear pain, tingling, tingling mouth and tingling throat to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received a dose of Shingrix on left arm and had side effects lasting two weeks included generalized muscle pains and side effects lasting three weeks included muscle pain on left arm where vaccine was administered; muscle spasms on left shoulder blade and neck; cervical pain; left ear ache; tingling of left side of head, mouth and throat.
Nurse administered hepatitis B vaccine to baby at 1010 on 4/8/10 -> baby developed bilateral pneumothorax, neck swelling. Pt transferred emergently to another facility.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/29/2023 Discharge Date: Apr 1, 2023  PRESENTING PROBLEM: COVID [U07.1]   HOSPITAL COURSE: Patient is a 67-year-old male with a past medical history significant for end-stage renal disease on hemodialysis, insulin dependent diabetes mellitus type 2, chronic heart failure with preserved ejection fraction, atypical atrial flutter and hypertension who presented with cough and shortness of breath and was diagnosed with COVID-19.   A chest x-ray was negative for infiltrate.  Secondary to oxygen requirements the patient was started Decadron and provided with supportive care. Remdesivir not started due to ESRD. Patient had dialysis during this admission .    New to this MD, 4/1/2023 seen and examined with wife, home O2 delivered. He is awake and alert, no CP no SOB , cough had imrpoved post O2 nasal cannula
My fiancé got COVID-19 and after his diagnosis, he started isolating. As soon as I started getting symptoms, I went for a PCR test on June 7 the day after. It started with a sore throat and then my sinuses were greatly affected. It felt like a bad sinus infection. My eyes were constantly burning and watering. It felt like I was crying nonstop. When I got the confirmed diagnosis on June 8, I called my doctor to see if I could get Paxlovid and I had an appointment on June 9. She prescribed that to me, and I took that right away. It helped by the next day. The sinus infection started to feel better, but I still had the sore throat. After 5 days, I tested to see if I was no longer positive, but I still was. Around Day 9, the line on the tests were getting fainter. I thought that hopefully that it would be negative soon. I finished the 5-day course of the Paxlovid. Day 11, my antigen came back positive before the control line could even show. I never cleared it, it just got worse. Symptom wise, it was the sore throat and pressure in my ears. I just had a slight cough that wasn?t too bad. No fever or body aches. I continued to test positive until Day 17 when I tested negative.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients. The patients medical history and current conditions were not reported. It was reported that an unspecified number of patients have received improperly stored doses of GARDASIL (strength, dose and frequency not reported) on 15-OCT-2014. No symptoms reported. Product quality complaint was not reported. The outcome of the event is unknown. Additional information has been requested.
Terrible red rash that is the size of the grapefruit; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Terrible red rash that is the size of the grapefruit) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Terrible red rash that is the size of the grapefruit). At the time of the report, RASH ERYTHEMATOUS (Terrible red rash that is the size of the grapefruit) had resolved.            No concomitant medication was reported. Patient did not receive any treatment for the event.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: TCR : AE outcome updated to recovered. No treatment was received. The patient received second dose without any issues.
Shot administered while standing and removing long sleeve tee shirt and arm above my head..  No warning, no cleaning, no bandaid.  Immediate excruciating  pain in right shoulder that never subsided with limited use of my right arm.  Symptoms were addressed  to treat with ibuprofen, ice packs, rest and to give it time to get better for the first three months. by Primary Care doctor.  An orthopedic  clinic ordered MRI with Physical therapy for three months.  Again, little improvement.  Told to give it time.  With continuous pain and limited use of right arm sought second opinion which resulted in surgery and now 8 months of recovery  lie ahead
Janssen 5/19/21 Asymptomatic COVID.  Hospital Course:  Patient admitted 2/5/22 with weakness, COVID + for  6 days prior to admission but with no Pulm symptoms. CT abd showed Right pyelonephritis and Lewft kidney mass and Bladder wall thickening. He was seen by ID and Rocephin was started. Blood cultures are no groth. Urine cultre + E.Coli. ID has deescalated Atbx to PO. he remains on room air. PE, Awake alert No distress, Lungs cTA, Heart RRR, Abd soft Non tender.  Discharged 2/8/22
But I got the flu type A anyways; Initial information received on 18-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-HCP.  This case involves an unknown age and unknown gender patient who got the flu type a after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (with an unknown strength, formulation, dose, frequency, route, expiry date, batch number, administration site) for prophylactic vaccination.   On an unknown date the patient got the flu type a (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event    Outcome was Unknown for the event but i got the flu type a anyways.
Patient experienced fever, shivering, and diarrhea - started a couple of hours after receiving the vaccine and persisted throughout the evening/night. He woke up the next day and felt better.
Chest pain, fever, headache and fatigue starting morning after vaccination. Progression of chest pain prompting evaluation in the emergency room where he was found to have a Troponin of 23,000 (nl less then 50). D'Dimer mildly elevated. ST changes on EKG. CTA negative. LFT mildly elevated. Sent to hospital where admitted to cardiology service pm 5/19 and given a diagnosis of myocarditis.  Still under care at this time of report.
Patient states received his COVID-19 vaccine booster; heart rate go up; blood pressure drop; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): RA2021US195563 (RA).  A 68 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 68 years as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (dose number unknown, primary Immunization series complete but unknown manufacturer), for covid-19 immunisation. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Patient states received his COVID-19 vaccine booster"; HEART RATE INCREASED (non-serious), outcome "recovered", described as "heart rate go up"; BLOOD PRESSURE DECREASED (non-serious), outcome "recovered", described as "blood pressure drop". Relevant laboratory tests and procedures are available in the appropriate section.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Approximately a few weeks after my 4th dose vaccination I contracted COVID-19 and had the following symptoms: Runny nose, Fever, Body aches. I called my doctor and was prescribed with Paxlovid for 5 days and have been taking it ever since and today is actually my last day and have fully recovered from my symptoms so far.
pt recvd vax & had inconsolable cry for 5 hrs & also high pitched crying at times; low grade fever of 100.6; tx w/ apap exery 4 hrs p/ vax;
Small red local reaction at inj site on LT arm. Nausea and vomiting evening 1 day later. Patient took BENADRYL - OTC.
Approximately 30 - 40 minutes after the injection I began to feel numbness in the fingers of my left hand, it radiated throughout my and up through my left arm. Within another hour it settled back down into my hand and my hand has had numbness in it ever since. I have reported this to my doctor and have seen a physical therapist weekly for the past month. All they can do is shrug their shoulders and scratch their heads. It is obvious this is a direct result of the vaccine and they have no idea on how to proceed with treatment. I am scheduled to meet with an Orthopedic doctor next week.
This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received PREVNAR 13 (lot number and expiration date were unknown), via an unspecified route of administration on 16Nov2018 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein)  2 weeks ago (16Nov2018). The patient noticed dark orange to light orange urine for about 10 days on Nov2018. The outcome of the event dark orange to light orange urine was unknown. Information on the batch/lot number has been requested.
area is still very hot to the touch; This case was reported by a consumer via interactive digital media and described the occurrence of injection site warmth in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th August 2021, the patient received the 1st dose of Shingrix. In August 2021, less than a week after receiving Shingrix, the patient experienced injection site warmth. On an unknown date, the outcome of the injection site warmth was not recovered/not resolved.   It was unknown if the reporter considered the injection site warmth to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient himself or herself. The age at vaccination was not reported. The patient had his/her first dose of Shingrix on Friday and the area was still very hot to the touch.  The patient asked if it was normal?
Felt dizzy; extreme back pain; Cannot stand; Cannot sit; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (extreme back pain), DYSSTASIA (Cannot stand), SITTING DISABILITY (Cannot sit) and DIZZINESS (Felt dizzy) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 032M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FAMOTIDINE (PEPCID AC), CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), ZINC and FOLIC ACID for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced BACK PAIN (extreme back pain), DYSSTASIA (Cannot stand) and SITTING DISABILITY (Cannot sit). On an unknown date, the patient experienced DIZZINESS (Felt dizzy). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency and METHYLPREDNISOLONE (MEDROL [METHYLPREDNISOLONE]) at an unspecified dose and frequency. At the time of the report, BACK PAIN (extreme back pain), DYSSTASIA (Cannot stand), SITTING DISABILITY (Cannot sit) and DIZZINESS (Felt dizzy) outcome was unknown. Not Provided          Concomitant products included fish oil.  Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MODERNATX, INC.-MOD-2021-051431 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-051431:
SUSPECTED COVID-19 INFECTION; PARTIAL PARALYSIS OF RIGHT SIDE; This spontaneous report received from a patient via a company representative of Johnson and Johnson Law Department and concerned a male patient of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was in perfect health until after commencement of this COVID outbreak. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: Unknown) dose was not reported, 1 total, start therapy date was not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. In JUN-2021, the patient experienced partial paralysis of his right side, which was for ten (10) months (JUN-2021 to APR-2022) and was quite severe, and once it abated, the residual effects were still thoroughly felt daily.  On an unspecified date, the patient experienced breathing difficulties that at times border on critical, loss of sense of taste and smell. Currently patient was suffering from "long-haul" effects that were yet to abate that resulted in injuries and injurious effects. The patient suffered from the COVID-19 virus (suspected covid-19 infection), and told that there were unknown possible to further complications that might happen down the line. The patient reported that due to the contracting of covid, the right side of body was slightly, yet impactfully, paralyzed and yet had to regain full function and movement. The patient had injuries and sickness. It was reported that partial paralysis of his right side, and the accompanying breathing difficulties, both of which persist in fluctuating percentages of severity: also, the loss of small and taste, which had yet to return to it's pre-infection state. The damage to the plaintiff, much of which appeared to be irreparable (paralysis of the right side, breathing problems, and a loss of taste and smell).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from partial paralysis of right side, and suspected covid-19 infection. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20220752482. This report was associated with product quality complaint: 90000243775.; Sender's Comments: V0- Medical Assessment comment not required as per standard operating procedure for legal case
also taking a medication that suppresses her immune system; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (159558). The reporter is the parent.  A female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Jul2023 as dose number unknown, single (Lot number: GJ6796) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNE SYSTEM DISORDER (non-serious), outcome "unknown", described as "also taking a medication that suppresses her immune system". No follow-up attempts are possible. No further information is expected. Additional information: Patient took a covid shot last Jul2023 bivalent booster code GJ6796. Patient was also taking a medication that suppresses her immune system. Reporter wanted to know if her wife needed a new shot for winter, is it the new booster.  No follow-up attempts are possible. No further information is expected.
Information has been received from a nurse practitioner, concerning a 67 year old male patient, who on 24-JUL-2007 was vaccinated with a dose of PNEUMOVAX 23 vaccine (Lot # not provided). On 25-JUL-2007, he experienced a reaction in the arm where the vaccine was administered, specified as pain and swelling from the administration site down to his elbow. At the time of this report, the patient had not recovered from th events. The patient sought  unspecified medical attention. Additional information has been requested.
This spontaneous report as received from a nurse via a company representative refers to a 55 year old female patient. On 14-JAN-2013 the patient was vaccinated with ZOSTAVAX lot # H019042, 0.65 ml once. On 16-JAN-2013, stated as about 2 days after she got the shot, the patient developed blisters and redness on the upper half of the arm she got the vaccine in. The patient sought medical attention and was treated with BENADRYL. The patient came back to the office on 25-JAN-2013 and there was "barely a red spot". The outcome of blisters and redness on the upper half of the arm she got the vaccine in was reported as recovered/resolving. No action was taken regarding the ZOSTAVAX. Relatedness for blisters and redness on the upper half of the arm she got the vaccine in and ZOSTAVAX was not provided by the reporter. The case was cross referenced with case 1303USA001535. Additional information has been requested.
Patient reported nausea post vaccine administration. She said she ate breakfast in the morning. She denies itching, shortness of breath, or chest pain. She felt better after 15 minutes. She will follow up at eh office she works at later.
ITCHING ON CHEST, ARMS AND LEGS; A HARD TIME SLEEPING; RASH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included sulfa drugs allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN, expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 around 14:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced a hard time sleeping. On APR-2021, the subject experienced rash. On 01-APR-2021, around 19:00 the subject experienced itching on chest, arms and legs. On 02-APR-2021, treatment medications included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itching on chest, arms and legs, and rash, and the outcome of a hard time sleeping was not reported. This report was non-serious.
Information has been received from a registered nurse referring to three patients of unknown age and gender. There was no medical history or concurrent condition reported. On unknown dates, 3 doses of improperly stored LIQUID PEDVAXHIB (lot # J016185 with expired date 02-OCT-2016, dose and route were unknown) were administered to the patients. No concomitant medication was provided. No adverse effects were reported. Additional information has been requested.
Menveo vaccine given on left deltoid at 10:44am by LVN.  A few minutes after administration, patient stated that "she felt funny" Per LVN, patient looked pale. LVN gave patient water. Patient stated her arms feel "prickling" and then heavy.  LVN told patient she would grab MD. Dr. walked into room and noticed patient was lethargic, laying on her back, bilateral eye twitching, hands stiff/shaky. Patient stated, "can't move my hands, my stomach/legs hurt". Dr, called 911. Vital signs: BP 152/92 on right arm, heart rate-116.  BP rechecked, 138/85, heart rate-109. 911 responders arrived and placed patient on gurney. Patient complaining of dizziness, bilateral leg/arm numbness, not in respiratory distress.